Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Peetz Christopher sold 20,000 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 4, 2026 · Filed Nov 4, 2026
On Nov 4, 2026, Peetz Christopher (Director, CHIEF EXECUTIVE OFFICER) sold 20,000 Mirum Pharmaceuticals, Inc. shares at US$90.00 for US$1.8M under a trading plan, leaving 206,637 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$90.00
- Value
- US$1.8M
- Holding after
- 206,637 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | Option exercise | 20,000 | US$2.94 | 226,637 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 20,000 | US$90.00 | 206,637 | Direct |
Source
Download original · View original at SEC
Related
- Mirum Pharmaceuticals, Inc.
- Peetz Christopher
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Peetz Christopher · Sep 3, 2026
- Form 4 · Peetz Christopher · Aug 11, 2026
- Form 4 · Peetz Christopher · Jul 8, 2026
- Form 4 · Peetz Christopher · Jun 2, 2026
- Form 4 · Ramasastry Saira · Nov 17, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Brege Laura · Nov 13, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Bjerkholt Eric · Sep 15, 2026